Literature DB >> 2268345

A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes).

Y Kobayashi1, M Y Momoi, K Tominaga, T Momoi, K Nihei, M Yanagisawa, Y Kagawa, S Ohta.   

Abstract

Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episode (MELAS) is a major group of heterogeneous mitochondrial disorders. To identify the defective gene, mitochondrial DNA from a patient with MELAS was sequenced by using amplified DNA fragments as sequencing templates. In 14.1 kbp determined out of 16.6 kbp of the whole mitochondrial gene, at least 21 nucleotides were different from those of a control human mitochondrial DNA. One of the substitutions was a transition of A to G in the tRNA(Leu) (UUR) gene at Cambridge nucleotide number 3,243. This nucleotide is conserved not only in many mitochondrial tRNAs but in most cytosolic tRNA molecules. An Apa I restriction site was gained by the substitution of this nucleotide. The Apa I digestion of the amplified DNA fragment revealed that all independent 6 patients had G at nucleotide number 3,243 in their mitochondrial DNAs, but none of 11 control individuals had G at this position. This result strongly suggests that the mutation in the mitochondrial tRNALeu gene causes MELAS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2268345     DOI: 10.1016/s0006-291x(05)80860-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  84 in total

Review 1.  Molecular biology of neurological diseases.

Authors:  W J Cumming
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

2.  Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy.

Authors:  M Yoneda; A Chomyn; A Martinuzzi; O Hurko; G Attardi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

3.  The mutant mitochondrial genes in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) were selectively amplified through generations.

Authors:  Y Kobayashi; K Ichihashi; S Ohta; K Nihei; Y Kagawa; M Yanagisawa; M Y Momoi
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

4.  Genetic analysis of three pedigrees of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS)

Authors:  W Sato; K Hayasaka; K Komatsu; Y Sawaishi; K Sakemi; Y Shoji; G Takada
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

Review 5.  Structure and function of the mitochondrial genome.

Authors:  D A Clayton
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 6.  Hitting the brakes: termination of mitochondrial transcription.

Authors:  Kip E Guja; Miguel Garcia-Diaz
Journal:  Biochim Biophys Acta       Date:  2011-11-25

7.  Mitochondria and dystonia: the movement disorder connection?

Authors:  D C Wallace; D G Murdock
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

8.  Chloroplast heteroplasmicity is stabilized by an amber-suppressor tryptophan tRNA(CUA).

Authors:  W Yu; R J Spreitzer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 9.  Pathways to disease from natural variations in human cytoplasmic tRNAs.

Authors:  Jeremy T Lant; Matthew D Berg; Ilka U Heinemann; Christopher J Brandl; Patrick O'Donoghue
Journal:  J Biol Chem       Date:  2019-01-14       Impact factor: 5.157

Review 10.  Non-coding RNAs and disease: the classical ncRNAs make a comeback.

Authors:  Rogerio Alves de Almeida; Marcin G Fraczek; Steven Parker; Daniela Delneri; Raymond T O'Keefe
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.